"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 7

Issue 7 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Where our team of guest writers discuss what they think about the current NGP US Issues.

Peter Duncan
Director of Business Development

Can digital pathology save drug development?

Peter Duncan of Definiens discusses the potential of digital pathology.
07 Jul 2010
Drug Discovery
1 of 8 Previous | Next
Drug Discovery

Driving Discovery


Drug discovery needs all the help it can get. NGP talks problems and solutions with four gene genies: IQuum’s Shuqi Chen, Sequenom’s Elizabeth Dragon, Cellumen’s D. Lansing Taylor, and X from Assuragen.

No Comments

MicroRNAs – keep your research on track


The use of new technologies to overcome many of the initial challenges in microRNA research will allow comprehensive studies of microRNA expression patterns and identification of microRNA biomarkers in cancer and other diseases over the next few year

No Comments

Boronic acids in drug discovery: from starting materials to approved drugs


Few medicinal chemists know that the palladium-catalyzed cross-coupling of organoboron compounds was observed in 1978 by Ei-Ichi Negishi.

No Comments

A Solution to the Sample Management Bottleneck


DNA Accessibility Now Drives Genomic Medicine and Identification

No Comments

Application of proteomics technologies to biomarker discovery and development – challenges and solutions


In recent years, proteomic technologies have led to enormous advances in basic research and medicine. The impact that these technologies can have on a more complete understanding of the processes of life is only now beginning to be realized.

No Comments
1 of 8 Previous | Next